Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Medi Bone Care
- Development stage
- Unknown
- Lead developer
- Medi-Crescent Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Medi Bone Care is an oral nutritional supplement distributed by Medi-Crescent Pharma, a Kenyan pharmaceutical wholesaler. It is formulated to support bone health and assist in the prevention of bone loss, particularly in conditions such as osteoporosis. As a nutraceutical product, it likely contains a combination of essential vitamins and minerals, such as calcium and vitamin D, which are critical for maintaining bone mineral density and structural integrity. The product is marketed as a supportive measure for individuals at risk of bone-related disorders and is part of a broader portfolio of health supplements provided by the company.
- Brand names
- Medi Bone Care
Beyond the preview
Go deeper on Medi Bone Care.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Medi Bone Care.